Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2023

Mar 7, 2023

34491_dirs_2023-03-07_96d7bf76-7d77-4e19-a55c-917756760ec9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2023-03-03

Reporting Person: Barton Shane (VP & Corporate Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-03 Common Stock M 12722 Acquired 21422 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-03 Restricted Stock Units $ M 12722 Disposed Common Stock (12722) Direct

Footnotes

F1: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.